Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01095432 · ClinicalTrials.gov registry record
Partial Wave Spectroscopic Detection of Colon Cancer Risk
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 40
- Enrollment target
NCT01095432: Completed study, sponsored by University of Chicago.
NCT01095432 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01095432 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to study samples of rectal mucosa (the moist lining of the rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and have a history of ulcerative colitis (UC).
Primary Outcome
Samples will be collected and then shipped to Northwestern University for analysis using PWS. This is to assess accuracy of detecting the risk for colon cancer.
Interventions
- PROCEDURE PWS Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-11 |
What the finished NCT01095432 record still lists
NCT01095432 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PWS Testing is the first listed.
NCT01095432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01095432 about?
NCT01095432 is a clinical study titled "Partial Wave Spectroscopic Detection of Colon Cancer Risk". The purpose of this study is to study samples of rectal mucosa (the moist lining of the rectum) using a new light scattering technology, called partial wave spectroscopy (PWS) in patients who will undergo a standard of care colonoscopy or a flexible sigmoidoscopy and have a history of ulcerative col...
What is the current status of trial NCT01095432?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2010-03. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01095432?
The interventions under investigation include: PWS Testing (PROCEDURE).
Who is sponsoring clinical trial NCT01095432?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia